CLINICAL_TRIALS
research
· 2026-03-30
Clinical Trial Update: A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. [Phase 2]
Summary
A Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of LXE408 in adults with chronic Chagas disease, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chagas Disease | Phase 2 | Status: RECRUITING